Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

NCT06663111 · clinicaltrials.gov ↗

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

OTHER: Blood samples for PK
OTHER: Blood samples for PK

Sponsor

Haukeland University Hospital

Collaborators

[object Object]